Literature DB >> 27035882

Effect of green tea catechins on gastric mucosal dysplasia in insulin-gastrin mice.

Takashi Ohno1, Masahiro Ohtani1, Hiroyuki Suto1, Makoto Ohta2, Yoshiaki Imamura2, Hidetaka Matsuda1, Katsushi Hiramatsu1, Tomoyuki Nemoto1, Yasunari Nakamoto1.   

Abstract

Green tea catechins (GTCs) have been implicated in various physiological effects, including anti-carcinogenic activities. In the present study, we evaluated the effects of GTCs specifically on the development of gastritis and pre-malignant lesions in insulin-gastrin mice. Nine-week-old male INS-GAS mice (n=38) were supplemented with GTCs for 4 and 28 weeks, and their body weights, serum gastrin levels, histopathology and pro-inflammatory cytokine levels in gastric tissue and mucosal cell proliferation were monitored. Body weights of the GTC-treated mice were significantly lower than those of the untreated controls (P≤0.05). Serum gastrin levels were suppressed at the age of 37-weeks (P≤0.05). The histopathological scores indicated that the extent of dysplasia was significantly diminished (P≤0.05), although GTC supplementation did not affect the inflammation scores. The messenger RNA levels of interferon (IFN)-γ were significantly reduced at the age of 13 weeks (P≤0.05), although the changes did not reach statistical significance at the age of 37 weeks (P=0.056). The labeling index of Ki-67 immunohistochemistry was significantly decreased (P≤0.05). These results demonstrated that GTCs may play a protective role in the development of gastritis and pre-malignant lesions via an IFN-γ, gastrin, and mucosal cell proliferation-dependent mechanism in this rodent model and potentially in humans.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27035882     DOI: 10.3892/or.2016.4717

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  1 in total

Review 1.  Prevention of Gastric Cancer: Eradication of Helicobacter Pylori and Beyond.

Authors:  Tetsuya Tsukamoto; Mitsuru Nakagawa; Yuka Kiriyama; Takeshi Toyoda; Xueyuan Cao
Journal:  Int J Mol Sci       Date:  2017-08-03       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.